Merck receives patent for CRISPR tech in China
Source: Merck receives patent for CRISPR tech in China
Merck KGaA (MRK.XE) said Monday that it has received a patent for its CRISPR genome-editing technology in China.
The CRISPR technology allows for precise chromosome modification in living cells, said Merck. Its applications range “from identifying genes linked to cancer and rare diseases to reversing mutations that cause blindness,” the company said.
Merck said that it will license CRISPR-related patents to interested parties.
The company has related patent filings in the U.S., Brazil, India and Japan. It also has had similar patents granted in Australia, Canada, Europe, Singapore and South Korea, it said.
Published at Mon, 23 Apr 2018 13:29:00 +0000
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.